lovastatin has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fritz, G; Henninger, C; Kelm, M; Merx, M; Ohlig, J; Zander, S | 1 |
| Brand, M; Fritz, G; Henninger, C; Huelsenbeck, J; Huelsenbeck, S; Schad, A; Wenzel, P | 1 |
2 other study(ies) available for lovastatin and Cardiotoxicity
| Article | Year |
|---|---|
Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
Topics: Aminoquinolines; Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Diastole; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Lovastatin; Male; Mice, Inbred C57BL; Neuropeptides; Pyrimidines; rac1 GTP-Binding Protein; Reactive Oxygen Species; Toxicity Tests, Subacute | 2018 |
Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.
Topics: Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Cardiotoxicity; Connective Tissue Growth Factor; DNA Damage; DNA, Mitochondrial; Doxorubicin; Female; Fibrosis; Gene Expression Profiling; HSP70 Heat-Shock Proteins; Interleukin-6; Lovastatin; Mice, Inbred C57BL; Myocardium; Natriuretic Peptide, Brain | 2015 |